⌕
Pacira BioSciences · PCRX · Nasdaq
Tenet 56 · Mixed
Compare
$36.48+0.05%At closeTenet 56 · Mixed
$36.48+0.02 (+0.05%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

Pacira BioSciences (PCRX) Institutional Ownership

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice

1 figure withheld by our checks. Each blank figure names its reason.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (33 new · 94 increased · 86 reduced · 25 closed · 21 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 50 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
SHARES HELD BY 13F FILERS
withheld
withheld by our checks · 259 filers, Sep 30, 2026
# 13F FUNDS
259
13F VALUE
$1.2B
45.9M shares
Withheld: the 13F filers report more shares than the company has outstanding, which happens when shared or lent shares are counted twice. The filer count, shares and value are as filed.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Oct 30, 2026Cross ShawnChief Financial OfficerDisposed · Tax withholding9,540$36.39↗
Oct 8, 2026Riker Lauren BullaroSenior Vice President, FinanceAcquired · Option exercise6,000$32.35↗
Oct 8, 2026Riker Lauren BullaroSenior Vice President, FinanceDisposed · Open-market sale6,000$36.32↗
Oct 8, 2026Riker Lauren BullaroSenior Vice President, FinanceDisposed · Option exercise6,000Stock Option (Right to Buy)—↗
Aug 17, 2026SLONIN JONATHANChief Medical OfficerDisposed · Open-market sale3,040$23.23↗
Jun 11, 2026Riker Lauren BullaroSenior Vice President, FinanceDisposed · Open-market sale6,115$23.50↗
Jun 10, 2026Hirawat SamitdirectorAcquired · Grant / award6,405—↗
Jun 10, 2026Hirawat SamitdirectorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026CHRISTIE CHRISTOPHERdirectorAcquired · Grant / award6,405—↗
Jun 10, 2026CHRISTIE CHRISTOPHERdirectorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026WIGGANS THOMAS GdirectorAcquired · Grant / award32,675Stock Option (Right to Buy)—↗
Jun 10, 2026Young AlethiadirectorAcquired · Grant / award6,405—↗
Jun 10, 2026Young AlethiadirectorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026YANG MICHAEL J.directorAcquired · Grant / award6,405—↗
Jun 10, 2026YANG MICHAEL J.directorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026BIGAL MARCELOdirectorAcquired · Grant / award6,405—↗
Jun 10, 2026BIGAL MARCELOdirectorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026Froimson MarkdirectorAcquired · Grant / award6,405—↗
Jun 10, 2026Froimson MarkdirectorAcquired · Grant / award10,891Stock Option (Right to Buy)—↗
Jun 10, 2026Brege LauradirectorAcquired · Grant / award6,405—↗

* Holdings as reported for Sep 30, 2026, 50 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How many 13F filers hold Pacira BioSciences?

Pacira BioSciences was held by 259 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.